CAS: 93957-54-1; Rel-(3R,5S,E)-7-(3-(4-Fluorophenyl)-1-Isopropyl-1H-Indol-2-yl)-3,5-Dihydroxyhept-6-Enoic Acid

• 英文名称Rel-(3R,5S,E)-7-(3-(4-Fluorophenyl)-1-Isopropyl-1H-Indol-2-yl)-3,5-Dihydroxyhept-6-Enoic Acid
• 中文名称富伐他丁
• IUPAC名称(3R,5S,E)-7-(3-(4-fluorophenyl)-1-isopropyl-1H-indol-2-yl)-3,5-dihydroxyhept-6-enoic acid
• 其它别名Fluvastatin; Fluvastatin Na; Fluvastatin Sodium; Methyl-(+/-)-(E)-7-[3'-(4-Fluorophenyl)-1'-(1-Methylethyl)Indol-2'-Yl]-3,5-Dihydroxy-6-Heptenoate; Fluvastatin[methyl-(±)-(E)-7-[3’-(4”-Fluorophenyl )-1’-(1”-Methylethyl)Indol-2’-Yl]-3,5- Dihydroxy-6- Heptenoate ]; Fluvastatinc24H26Fn04; (3S,5R,E)-7-(3-(4-Fluorophenyl)-1-Isopropyl-1H-Indol-2-yl)-3,5-Dihydroxyhept-6-Enoic Acid; Lipaxan
• CAS编号93957-54-1
• MFCD编号:MFCD00865715
• EINECS号:695-664-7
• FDA UNII编号:4L066368AS
• 分子式:C24H26FNO4
• 分子量:411.47
• 产品CID: 1983474
• 同类组份化合物CAS93957-55-2 (sodium)94061-81-1 (sodium)93957-54-1 (free acid)500103-16-2 (calcium)1009811-63-5 (potassium)
• 产品分类原料药 → 循环系统用药 → 调节血脂药

• 相似结构搜索
• 产品信息参考;
• InChIKey: FJLGEFLZQAZZCD-NDDZYTDBNA-N
• InChI=1S/C24H26FNO4/c1-15(2)26-21-6-4-3-5-20(21)24(16-7-9-17(25)10-8-16)22(26)12-11-18(27)13-19(28)14-23(29)30/h3-12,15,18-19,27-28H,13-14H2…
• 计算化学: 氢键受体数5.0氢键供体数3.0可旋转键数8.0

物理性质

• 熔点194-197 °C
• 沸点681.8±55.0 °C at 760 mmHg
• 闪点366.1±31.5 °C
• 密度1.2±0.1 g/cm3
• pKa:4.27±0.10(预测)
• PSA:82.69
• LogP:3.62
• 折射率1.587
• 蒸汽压0.0±2.2 mmHg at 25°C
• 溶解性Water 25 mg/mL DMSO 100 mg/mL Ethanol 25 mg/mL
• 外观形态淡黄色至黄色粉末
• 储存条件2-8°C
• 产品应用该化合物用作治疗由动物脂肪和胆固醇含量丰富的饮食引起的超胆固态血症(IIA和IIB型);它起到A(HMG-COA)氢氧甲基甘油-胆固酰胺还原酶抑制剂的作用,以降低胆固酚水平.

MSDS等安全信息

• GHS象形图
• GHS符号GHS07 & GHS05;
  注释: Exclamation mark & Corrosion
• 危险类别急性毒性 类别4(经口)
  皮肤腐蚀/刺激 类别2
  严重眼损伤 类别1
  水生慢性毒性 类别3
• 警示词Danger(危险)
• 危险描述H302 |吞咽有害.
  H315 |造成皮肤刺激.
  H318 |造成严重眼损伤.
  H412 |对水生生物有害并具有长期持续影响.
• 防范说明P273-P305+P351+P338
• UN编号UN 3272 3/PG 3
• 危险品标志Xi
• 安全声明S23-S26-S37
• WGK Germany3

欧盟法规

上下游产品

合成工艺路线路线简述

• 500731-93-1 = 93957-54-1
  反应条件:1.1 Reagents: Hydrochloric Acid Solvents: Acetonitrile,Water; 0.5 H,20 - 25 °C; 1.5 H,Rt1.2 Reagents: Sodium Hydroxide Solvents: Water; 0.3 H,Rt; 3 H,30 - 35 °C1.3 Reagents: Hydrochloric Acid Solvents: Water; Ph 4,0 - 10 °C1.4 Reagents: Dicyclohexylamine Solvents: Acetonitrile; 0 - 10 °C; 2 H,25 - 35 °C
  标题:An Efficient Industrial Process For The Preparation Of Fluvastatin Sodium
  作者:Reddy,M. S. N.; Reddy,B. K.; Reddy,C. K.; Kumar,M. K.; Rajan,S. T.; Et Al
  参考文献:Oriental Journal Of Chemistry 日期:2007 卷标:23(3) 页码:919-926]
  
  93957-55-2 = 93957-54-1
  反应条件:1.1 Reagents: Hydrochloric Acid Solvents: Dichloromethane,Water
  标题:Preparation Of Fluorine And Indole Containing Statin Derivatives As Hmg-Coa Reductase Inhibitors
  参考文献:China]
  
  93957-55-2 = 93957-54-1
  反应条件:1.1 Reagents: Hydrochloric Acid Solvents: Dichloromethane,Water
  标题:Preparation Of Polysubstituted Indoles Statin Lactone Dehydration Compounds Useful As Hag-Coa Reductase Inhibitor
  参考文献:China]
  
  = 93957-54-1 [标题:Reaction Conditions
  标题:Process For The Synthesis Of Hmg-Coa Reductase Inhibitors
  参考文献:United States]
  
  = 93957-54-1 [标题:Reaction Conditions
  标题:Process For The Preparation Of Statins And Their Pharmaceutically Acceptable Salts Thereof
  参考文献:United States]
  
  = 93957-54-1 [标题:Reaction Conditions
  标题:Process For The Preparation Of A Statin Precursor
  参考文献:United States]
  
  = 93957-54-1 [标题:Reaction Conditions
  标题:Process For Preparation Of Intermediates For The Synthesis Of Statins
  参考文献:Italy]
  
  93957-50-7 + 1811523-40-6 = 93957-54-1 [标题:Reaction Conditions
  标题:Palladium-Catalyzed Synthesis Of 2-Alkenyl-3-Arylindoles Via A Dual α-Arylation Strategy: Formal Synthesis Of The Antilipemic Drug Fluvastatin
  作者:Kale,Ajit Prabhakar; Kumar,Gangam Srikanth; Kapur,Manmohan
  参考文献:Organic & Biomolecular Chemistry 日期:2015 卷标:13(45) 页码:10995-11002]
  
  375846-25-6 = 93957-54-1
  反应条件:1.1 Reagents: Diethylmethoxyborane,Sodium Borohydride Solvents: Methanol,Tetrahydrofuran; -85 - -75 °C1.2 Reagents: Sodium Bicarbonate Solvents: Ethyl Acetate,Heptane,Water
  标题:Process For The Preparation Of Fluvastatin And Salts Thereof Using Stereoselective Reduction As Key Step
  参考文献:India]
  
  375846-25-6 = 93957-54-1
  反应条件:1.1 Reagents: Triethylborane,Sodium Borohydride Solvents: Methanol,Tetrahydrofuran; -85 - -75 °C1.2 Reagents: Sodium Bicarbonate Solvents: Water; -85 - -75 °C
  标题:Process For The Preparation Of Fluvastatin And Salts Thereof Using Stereoselective Reduction With Trialkyl Borane As Key Step
  参考文献:India]
  
  = 93957-54-1 [标题:Reaction Conditions
  标题:Convenient Process For The Preparation Of Statins
  参考文献:United States]
  
  = 93957-54-1 [标题:Reaction Conditions
  标题:Process For The Preparation Of A Thioprecursor For Statins
  参考文献:United States]
  
  = 93957-54-1 [标题:Reaction Conditions
  标题:Process For Statins And Its Pharmaceutically Acceptable Salts Thereof
  参考文献:United States]
  
  = 93957-54-1 [标题:Reaction Conditions
  标题:Process For The Synthesis Of Rosuvastatin Calcium
  参考文献:United States]
  
  = 93957-54-1 [标题:Reaction Conditions
  标题:Preparation Of Isoindolinone Compounds As Gpr119 Modulators For The Treatment Of Diabetes,Obesity,Dyslipidemia And Related Disorders
  参考文献:World Intellectual Property Organization]
  
  = 93957-54-1 [标题:Reaction Conditions
  标题:Preparation Of Rosuvastatin Calcium
  参考文献:Argentina]
  
  = 93957-54-1 [标题:Reaction Conditions
  标题:A Novel Processes For The Preparation Of Hmg-Coa Reductase Inhibitors,Such As Rosuvastatin Calcium
  参考文献:India

海关参考信息

• 2901210000-乙烯
  2901220000-丙烯
  2905122000-异丙醇
  2905399001-1,3-丙二醇
• 💡 提示：海关信息按照顺序优先匹配，如需确认的海关信息，请参考相关资料。
• 详情请参考：📖 海关编码查询和海关进出口税则

专利信息

其他信息查阅

• ➥ 象形图和危险代码
• ➥ 防范代码详解
• ➥ 危险代码说明
• ➥ Globally Harmonized System
• ➥ REACH监管